Neuroprotective activities of natural products from marine macroalgae during 1999–2015
Date
2016
Authors
Alghazwi, M.
Kan, Y.
Zhang, W.
Gai, W.
Garson, M.
Smid, S.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Journal of Applied Phycology, 2016; 28(6):3599-3616
Statement of Responsibility
Mousa Alghazwi, Yen Qi Kan, Wei Zhang, Wei Ping Gai, Mary J. Garson, Scott Smid
Conference Name
Abstract
This review focuses on macroalgae-derived compounds with neuroprotective activity that may provide lead compounds for the prevention and treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s disease. Coverage is provided from 1999 to 2015. A total of 99 pure compounds have been reported. The main in vitro bioactivities of these compounds include inhibition of beta amyloid protein (Aβ), inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), reduction in oxidative stress, anti-inflammatory activity, inhibition of kinases, enhancement of neurite outgrowth and the reduction in dopaminergic neurotoxicity. The majority of these bioactive compounds are derived from Phaeophyceae (57.6 %), followed by Rhodophyta (28.3 %) and Chlorophyta (14.1 %). This review presents valuable knowledge on macroalgae-derived compounds and their known pathways of neuroprotection to further explore the potential of these compounds in preventing and treating neurodegenerative diseases.
School/Discipline
Dissertation Note
Provenance
Description
Published online: 5 August 2016
Access Status
Rights
© Springer Science+Business Media Dordrecht 2016